Claremont Financial Group »

Abbvie shares owned by Claremont Financial Group

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Claremont Financial Group from 13F filings

Historical chart of Claremont Financial Group investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Claremont Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Claremont Financial Group

Quarter filed Position value Share count Share price at filing
2022-03-31 $126k 727 173.32
2021-12-31 $98k 727 135.40

More positions owned by Claremont Financial Group

Vanguard FTSE Developed Markets ETF Exchange Traded Fund (VEA)
SPDR Gold Shares Exchange Traded Fund (GLD)
iShares Core S&P Mid-Cap Exchange Traded Fund (IJH)
iShares Residential & Multisector RE ETF Exchange Traded Fund (REZ)
Vanguard FTSE Emerging Markets ETF Exchange Traded Fund (VWO)
PIMCO Active Bond ETF Exchange Traded Fund (BOND)
Spdr S&p 500 Etf Exchange Traded Fund (SPY)
Vanguard Growth ETF Exchange Traded Fund (VUG)
SPDR Portfolio S&P 600 Sm Cap ETF Exchange Traded Fund (SPSM)
Honeywell International Common Stock (HON)
Union Pacific Corp Common Stock (UNP)
Pfizer Common Stock (PFE)
Invesco S&P 500 Equal Weight ETF Exchange Traded Fund (RSP)
AbbVie Common Stock (ABBV)
Bristol-Myers Squibb Company Common Stock (BMY)

View all positions for Claremont Financial Group

Top funds holding Abbvie

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
Geode Capital Management
Capital Research Global Investors
Charles Schwab Investment Management
Bank of America Corporation
Northern Trust
Bank of New York Mellon
Capital World Investors
Legal & General Group
Franklin Resources
Ameriprise Financial

View all funds holding Abbvie